Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immune (Idiopathic) Thrombocytopenic Purpura”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01719692
What this trial is testing

Low-dose Rituximab Regimens in Chinese Adult Patients With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenic Purpura
Institute of Hematology & Blood Diseases Hospital, China 100
Large-scale testing (Phase 3)Study completedNCT00504075
What this trial is testing

Find How Safe and Effective GAMMAPLEX® is in Subjects With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Chronic Idiopathic Thrombocytopenic Purpura
Bio Products Laboratory 35
Large-scale testing (Phase 3)Study completedNCT02391272
What this trial is testing

Study on Recombinant Human Thrombopoietin in Management of ITP in Pregnancy

Who this might be right for
Immune ThrombocytopeniaPregnancy
Shandong University 31
Testing effectiveness (Phase 2)Study completedNCT00475423
What this trial is testing

MabThera (Rituximab) in Patients With Idiopathic Thrombocytopenic Purpura.

Who this might be right for
Idiopathic Thrombocytopenic Purpura
Hoffmann-La Roche 122
Not applicableStudy completedNCT06408324
What this trial is testing

Evaluation of the Use of Thrombopoietin Receptor Agonists in Adults With Primary ITP in Europe

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
European Research Consortium on ITP 275
Testing effectiveness (Phase 2)WithdrawnNCT03965624
What this trial is testing

Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia

Who this might be right for
Immune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia
Assistance Publique - Hôpitaux de Paris
Testing effectiveness (Phase 2)Study completedNCT00441090
What this trial is testing

Study of AKR-501 Tablets Taken Orally Once Daily for 28 Days in Patients With Chronic Idiopathic Thrombocytopenic Purpura (ITP)

Who this might be right for
Chronic Idiopathic Thrombocytopenic PurpuraPurpura, Thrombocytopenic, Idiopathic
Eisai Inc. 64
Not applicableUnknownNCT05506033
What this trial is testing

Optimization of Glucocorticoid Taper Strategies for SLE-ITP

Who this might be right for
Lupus Erythematosus, SystemicPurpura, Thrombocytopenic, IdiopathicGlucocorticoids+1 more
Fujian Medical University Union Hospital 120
Not applicableStudy completedNCT07805408
What this trial is testing

A Real World Study of Treatment Patterns and Effectiveness of Standard of Care in Primary Immune Thrombocytopenia Patients

Who this might be right for
Immune Thrombocytopenia
Novartis Pharmaceuticals 3,714
Not applicableLooking for participantsNCT05152238
What this trial is testing

ITP Registry and Accompanying Biospecimen Collection

Who this might be right for
Immune Thrombocytopenia
Jena University Hospital 1,100
Testing effectiveness (Phase 2)Study completedNCT00117143
What this trial is testing

Amgen Megakaryopoiesis Protein 2 (AMG 531) in Thrombocytopenic Subjects With Immune Thrombocytopenic Purpura (ITP)

Who this might be right for
Thrombocytopenic Purpura
Amgen 16
Not applicableNot Yet RecruitingNCT07268898
What this trial is testing

National Multicenter Retrospective Real-World Study on the Treatment Status of Newly Diagnosed and Persistent Primary Immune Thrombocytopenia (ITP) Patients

Who this might be right for
Immune Thrombocytopenia (ITP)
Institute of Hematology & Blood Diseases Hospital, China 500
Large-scale testing (Phase 3)Study completedNCT02868099
What this trial is testing

Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Kyowa Kirin China Pharmaceutical Co., Ltd. 203
Testing effectiveness (Phase 2)Looking for participantsNCT06929299
What this trial is testing

A Phase Ib/II Clinical Trial of Multiple Doses of STSA-1301 Subcutaneous Injection in Healthy Subjects and Patients With Immune Thrombocytopenia (ITP)

Who this might be right for
Primary Immune Thrombocytopenia (ITP)
Jiangsu BioJeTay Biotechnology Co., Ltd. 56
Not applicableStudy completedNCT04943042
What this trial is testing

An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITP

Who this might be right for
Immune ThrombocytopeniaITP
Swedish Orphan Biovitrum 199
Large-scale testing (Phase 3)UnknownNCT05685420
What this trial is testing

Extension Study of Herombopag for Pediatric Patients With Chronic Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Jiangsu HengRui Medicine Co., Ltd. 117
Early research (Phase 1)Study completedNCT03951623
What this trial is testing

The Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMPL-523 in Immune Thrombocytopenia Patients

Who this might be right for
Immune Thrombocytopenia (ITP)
Hutchison Medipharma Limited 45
Testing effectiveness (Phase 2)Study completedNCT05757570
What this trial is testing

An Open-label Study of Povetacicept in Participants With Autoimmune Cytopenias (RUBY-4)

Who this might be right for
Idiopathic Thrombocytopenic PurpuraImmune ThrombocytopeniaWarm Autoimmune Hemolytic Anemia+1 more
Alpine Immune Sciences Inc, A Subsidiary of Vertex 30
Testing effectiveness (Phase 2)Study completedNCT01107951
What this trial is testing

Low-dose Rituximab and High-dose Dexamethasone as First Line Treatment for ITP

Who this might be right for
Immune Thrombocytopenic Purpura
Hospital Universitario Dr. Jose E. Gonzalez 21
Not applicableStudy completedNCT02287649
What this trial is testing

Polymorphism and Auto-reactive B and T Cells Subsets in Adult's Immune Thrombocytopenia (ITP)

Who this might be right for
Immune Thrombocytopenia
Assistance Publique - Hôpitaux de Paris 45
Next Page